Nicholas Finn

Dr. Georges L-Dumont University Centre
Moncton, NB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Sex-specific cytokine signatures as predictors of anti-PD1 therapy response in non-small cell lung cancer.

Sex-specific cytokine signatures as predictors of anti-PD1 therapy response in non-small cell lung cancer.

Journal: Frontiers in immunology

Published: February 25, 2025

Improvement in quality of life in MDS patients who become transfusion independent after treatment.

Improvement in quality of life in MDS patients who become transfusion independent after treatment.

Journal: Leukemia & lymphoma

Published: November 09, 2024

Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registry.

Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registry.

Journal: Annals of hematology

Published: September 03, 2024

Pneumonectomy for Osteosarcoma Metastases: Two Compelling Cases With Unique Radiology.

Pneumonectomy for Osteosarcoma Metastases: Two Compelling Cases With Unique Radiology.

Journal: Annals of thoracic surgery short reports

Published: January 22, 2024

Canadian real-world experience of asciminib treatment in heavily pre-treated chronic myeloid leukemia (CML) patients who failed multiple lines of tyrosine kinase inhibitor (TKI) therapy.

Canadian real-world experience of asciminib treatment in heavily pre-treated chronic myeloid leukemia (CML) patients who failed multiple lines of tyrosine kinase inhibitor (TKI) therapy.

Journal: Leukemia research

Published: June 22, 2023

The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry.

The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry.

Journal: Leukemia & lymphoma

Published: January 06, 2023

A natural history of lower-risk myelodysplastic syndromes with ring sideroblasts: an analysis of the MDS-CAN registry.

A natural history of lower-risk myelodysplastic syndromes with ring sideroblasts: an analysis of the MDS-CAN registry.

Journal: Leukemia & lymphoma

Published: September 12, 2022

High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes.

High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes.

Journal: Haematologica

Published: March 18, 2022

Pax-5 Protein Expression Is Regulated by Transcriptional 3'UTR Editing.

Pax-5 Protein Expression Is Regulated by Transcriptional 3'UTR Editing.

Journal: Cells

Published: November 17, 2021

Patient-reported fatigue refines prognosis in higher-risk myelodysplastic syndromes (MDS): a MDS-CAN study.

Patient-reported fatigue refines prognosis in higher-risk myelodysplastic syndromes (MDS): a MDS-CAN study.

Journal: British journal of haematology

Published: January 25, 2021

Peptide-Affinity Precipitation of Extracellular Vesicles and Cell-Free DNA Improves Sequencing Performance for the Detection of Pathogenic Mutations in Lung Cancer Patient Plasma.

Peptide-Affinity Precipitation of Extracellular Vesicles and Cell-Free DNA Improves Sequencing Performance for the Detection of Pathogenic Mutations in Lung Cancer Patient Plasma.

Journal: International journal of molecular sciences

Published: November 02, 2020

Revised 15-item MDS-specific frailty scale maintains prognostic potential.

Revised 15-item MDS-specific frailty scale maintains prognostic potential.

Journal: Leukemia

Published: April 30, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026